Previous studies indicated that upregulating TCRζ partially recovers T cell function in patients with leukemia. In this study, we characterized the cytokine profile of TCRζ-transfected T cells from acute myeloid leukemia (AML) patients by Quantibody®Array Glass Chip. Firstly, the significantly lower expression of TCRζ in CD3 + /TCRζ + cells from AML patients was found. Increased secretion of IL-2, IL-8, IL-10, IL-13, IFN-γ, TNF-α, GM-CSF, growth-regulated oncogene (GRO), MIP-1b, and regulated on activation, normal T cell expressed and secreted (RANTES) could be detected in T cells from AML patients after TCRζ upregulating. We concluded that upregulating TCRζ in T cells from AML can alter the secretion profile of cytokines and chemokine which are involved in T cell proliferation and activation.
Findings
Acute myeloid leukemia (AML) is an aggressive disease with an unfavorable prognosis [1] [2] [3] . T cell immunodeficiency is a common characteristic in hematological malignancies which may be due to defective TCRζ. Previous studies showed that TCRζupregulation could be induced in CD3 + T cells from AML patients by IL-2, IL-7, and IL-12 [4] . In this study, we characterized the secretion profile of cytokines and chemokines related to T cell activation in TCRζ-IRES2-EGFP-transfected T cells from AML patients after TCRζupregulation.
First, significantly lower TCRζ expression in CD3 + /TCRζ + cells in AML (2.89 ± 2.6 %, n = 10) was found in comparison with healthy individuals (87.38 ± 15.67 %, n = 10) (p < 0.001) (Fig. 1a-c) . This result further supported our previous finding that T cell immunodeficiency might be due to low TCRζ signaling in T cells [5] [6] [7] [8] .
CD3 + T cells were sorted from PBMCs from four AML patients (Additional file 1: Table S1 ) who had TCRζ deficiency and then transfected with TCRζ-IRES2-EGFP or IRES2-EGFP, respectively, by nucleofection [9] . Significant upregulation of TCRζ in TCRζ-IRES2-EGFPtransfected CD3 + T cells was confirmed. Similar results were found in TCRζ downstream target factor Zap-70 ( Fig. 1d-f ) . Thus, TCRζ gene transfection could directly upregulate TCRζ and Zap-70 in T cells from AML patients as previously found in CML [9] .
Forced TCRζ chain expression can reverse TCR/ CD3-mediated signaling abnormalities and defective IL-2 production in T cells [9, 10] . In this study, we used Quantibody®Array Glass Chip (www.raybiotech.com) to quantitatively measure 20 human cytokines and chemokines in supernatants from TCRζ-IRES2-EGFPtransfected and IRES2-EGFP-transfected T cells from AML patients (Additional file 2). Increased secretion of IL-2, IL-8, IL-10, IL-13, IFN-γ, TNF-α, GM-CSF, growth-regulated oncogene (GRO), MIP-1b, and regulated on activation, normal T cell expressed and secreted (RANTES) and decreased secretion of IL-5 were found, while the secretion level of IL-1α, IL-1β, IL-4, IL-6, and IL-12 had no obvious change after TCRζupregulation. Moreover, the changes in the secretion levels of IL-10, MCP-1, MIP-1a, MMP-1, and VEGF were different in different AML samples (Fig. 2) . After TCRζ transfection, the IFN-γ secretion level was increased in all samples in the TCRζ-IRES2-EGFP group (median 71.46 pg/mL) compared with the pIRES2-EGFP group (median 42 pg/mL) (P = 0.253) because the basal level of IFN-γ in T cells from different AML patients was relatively different, ranging from 18.89 to 169.41 pg/mL in control cells and from 54.02 to 335.33 pg/mL in TCRζ-IRES2-EGFP cells. Thus, it could be understood that the increased secretion of IFN-γ was not statistically different in this study even though there was an obvious change in its level. Similar characteristic was found in TNF-α secretion level (Additional file 3: Figure S1 ). Interestingly, we found that the level of GM-CSF was significantly increased (21.63 ± 15.19 pg/mL for TCRζ-IRES2-EGFP cells vs. 1.96 ± 1.83 pg/mL for pIRES2-EGFP cells) (p = 0.045) (Fig. 2) , and IL-13, which is secreted by activated T cells and has synergistic effects with GM-CSF and G-CSF, was also upregulated after TCRζ gene transfection (Fig. 2) . Recently, increasing data have shown that GM-CSF has a variety of effects on the immune system including the activation of T cells, maturation of dendritic cells, and the ability to promote humoral and cell-mediated responses; thus, it has been incorporated into immunotherapy strategies [11, 12] .
In conclusion, we characterized the profile of cytokines and chemokines secretion in T cells after TCRζ gene 
